Skip to main content
logo
ExpreS2ion Biotech Holding AB (publ) (STO:EXPRS2)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.360
-0.035 (-2.51%)
Sep 4, 2026, 10:56 AM CET

STO:EXPRS2 Revenue

ExpreS2ion Biotech Holding AB had revenue of 11.55M SEK in the quarter ending June 30, 2026, with 237.73% growth. This brings the company's revenue in the last twelve months to 24.25M, up 136.71% year-over-year. In the year 2025, ExpreS2ion Biotech Holding AB had annual revenue of 12.21M with 56.00% growth.

Revenue (ttm)
24.25M
Revenue Growth
+136.71%
P/S Ratio
1.37
Revenue / Employee
1.28M
Employees
19
Market Cap
33.13M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202512.21M4.38M56.00%
Dec 31, 20247.83M-974.00K-11.07%
Dec 31, 20238.80M2.65M43.07%
Dec 31, 20226.15M-7.58M-55.21%
Dec 31, 202113.73M-1.53M-10.04%
Dec 31, 202015.26M1.43M10.37%
Dec 31, 201913.83M4.96M55.94%
Dec 31, 20188.87M-927.00K-9.46%
Dec 31, 20179.80M--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Magle Chemoswed Holding AB275.79M
Fluicell AB22.19M
AcouSort AB9.31M
OncoZenge AB5.97M
2cureX AB1.98M
NanoEcho AB1.13M
Alligator Bioscience AB681.00K
Pila Pharma AB275.74K
Revenue Rankings

ExpreS2ion Biotech Holding AB News

More News